Pressure overload-induced functional and metabolic impairments in type 2 diabetic hearts are ameliorated by inhibition of xanthine oxidase

被引:0
|
作者
Igaki, Y. [1 ]
Tanno, M. [1 ]
Kouzu, H. [1 ]
Tatekoshi, Y. [1 ]
Yano, T. [1 ]
Kuno, A. [2 ]
Sato, T. [1 ]
Miki, T. [1 ]
Miura, T. [1 ]
机构
[1] Sapporo Med Univ, Dept Cadiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan
[2] Sapporo Med Univ, Dept Pharmacol, Sapporo, Hokkaido, Japan
关键词
D O I
10.1093/ehjci/ehz872.055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P121
引用
收藏
页码:58 / 58
页数:1
相关论文
共 16 条
  • [1] Inhibition of xanthine oxidase ameliorates functional and metabolic impairment in type 2 diabetic hearts under pressure overload
    Igaki, Y.
    Osanami, A.
    Tanno, M.
    Sato, T.
    Ogawa, T.
    Yano, T.
    Kouzu, H.
    Miura, T.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3618 - 3618
  • [2] Xanthine Oxidase Inhibition With Febuxostat Attenuates Systolic Overload-Induced Left Ventricular Hypertrophy and Dysfunction in Mice
    Xu, Xin
    Hu, Xinli
    Lu, Zhongbing
    Zhang, Ping
    Zhao, Lin
    Wessale, Jerry L.
    Bache, Robert J.
    Chen, Yingjie
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (09) : 746 - 753
  • [3] Delayed Treatment Effects of Xanthine Oxidase Inhibition on Systolic Overload-Induced Left Ventricular Hypertrophy and Dysfunction
    Xu, X.
    Zhao, L.
    Hu, X.
    Zhang, P.
    Wessale, J.
    Bache, R.
    Chen, Y.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2010, 29 (4-6): : 306 - 313
  • [4] Xanthine oxidoreductase-mediated injury is amplified by upregulated AMP deaminase in type 2 diabetic rat hearts under the condition of pressure overload
    Igaki, Yusuke
    Tanno, Masaya
    Sato, Tatsuya
    Kouzu, Hidemichi
    Ogawa, Toshifumi
    Osanami, Arata
    Yano, Toshiyuki
    Kuno, Atsushi
    Miki, Takayuki
    Nakamura, Takashi
    Miura, Tetsuji
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2021, 154 : 21 - 31
  • [5] Ryanodine Receptor Type 2 Is Required for the Development of Pressure Overload-Induced Cardiac Hypertrophy
    Zou, Yunzeng
    Liang, Yanyan
    Gong, Hui
    Zhou, Ning
    Ma, Hong
    Guan, Aili
    Sun, Aijun
    Wang, Ping
    Niu, Yuhong
    Jiang, Hong
    Takano, Hiroyuki
    Toko, Haruhiro
    Yao, Atsushi
    Takeshima, Hiroshi
    Akazawa, Hiroshi
    Shiojima, Ichiro
    Wang, Yuqi
    Komuro, Issei
    Ge, Junbo
    HYPERTENSION, 2011, 58 (06) : 1099 - U363
  • [6] Bisacurone Ameliorated Pressure Overload-Induced Cardiac Hypertrophy in Experimental Rats Through Inhibition of Oxidative Stress and Bax/Caspase-3 Pathway
    Zeng, Xiaohong
    Gong, Houwen
    Zhang, Li
    Lan, Yaping
    Yang, Shuangyan
    Xu, Fengcheng
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2022, 18 (03) : 415 - 427
  • [7] Targeted disruption of ryanodine receptor type 2 in the heart suppresses pressure overload-induced cardiac hypertrophy but impairs cardiac functions
    Zou, Y
    Takano, H
    Qin, Y
    Yao, A
    Sakamoto, M
    Komuro, I
    EUROPEAN HEART JOURNAL, 2003, 24 : 12 - 12
  • [8] Gentisic acid attenuates pressure overload-induced cardiac hypertrophy and fibrosis in mice through inhibition of the ERK1/2 pathway
    Sun, Simei
    Kee, Hae Jin
    Jin, Li
    Ryu, Yuhee
    Choi, Sin Young
    Kim, Gwi Ran
    Jeong, Myung Ho
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (12) : 5964 - 5977
  • [9] The Cav3.2 T-Type Ca2+ Channel Is Required for Pressure Overload-Induced Cardiac Hypertrophy in Mice
    Chiang, Chien-Sung
    Huang, Ching-Hui
    Chieng, Hockling
    Chang, Ya-Ting
    Chang, Dory
    Chen, Ji-Jr
    Chen, Yong-Cyuan
    Chen, Yen-Hui
    Shin, Hee-Sup
    Campbell, Kevin P.
    Chen, Chien-Chang
    CIRCULATION RESEARCH, 2009, 104 (04) : 522 - U194
  • [10] Rho-kinase inhibition reverses impaired Ca2+ handling and associated left ventricular dysfunction in pressure overload-induced cardiac hypertrophy
    Olgar, Yusuf
    Celen, Murat Cenk
    Yamasan, Bilge Eren
    Ozturk, Nihal
    Turan, Belma
    Ozdemir, Semir
    CELL CALCIUM, 2017, 67 : 81 - 90